Literature DB >> 27916222

Acute Amiodarone Pulmonary Toxicity After Surgical Procedures.

Jirapat Teerakanok1, Pakpoom Tantrachoti1, Phumpattra Chariyawong1, Kenneth Nugent2.   

Abstract

Amiodarone can cause toxicity in several organs, including amiodarone-induced pulmonary toxicity which is a subacute or chronic complication. Amiodarone-induced acute respiratory distress syndrome (ARDS) in postoperative patients is a rare acute complication. The PubMed and Google Scholar databases were searched. Seven retrospective and prospective case series and 10 case reports of amiodarone-induced postoperative ARDS were reviewed. All patients received amiodarone chronically or during the perioperative period. Forty-three out of 285 patients (15%) reported in the retrospective and prospective studies developed amiodarone-induced ARDS. Most of the patients were men in age group 60-80 who had undergone cardiothoracic surgery. All patients had general anesthesia and exposure to high concentrations of oxygen. The onset of symptoms ranged from 2 hours to 2 weeks after surgery. The mortality rate of amiodarone-induced ARDS after surgery was approximately 10%. Ten case reports were evaluated using Naranjo criteria. Two cases had definite amiodarone toxicity, and 8 had probable toxicity based on these criteria. The incidence of amiodarone-induced postoperative ARDS was approximately 15% in these studies. Most operations involved cardiothoracic surgery. Elderly patients on high-dose and long-term amiodarone treatment were at increased risk. This diagnosis is challenging owing to the lack of definite diagnostic criteria; careful clinical evaluation and early drug withdrawal may reduce the severity of this complication. Copyright Â
© 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute respiratory distress syndrome; Amiodarone; Complication; Surgery; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 27916222     DOI: 10.1016/j.amjms.2016.08.013

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

Review 1.  Pharmacological Threat to Lungs: A Case Series and Literature Review.

Authors:  Omar Irfan; Jaleed A Gilani; Abeel Irshad; Babar Irfan; Javaid A Khan
Journal:  Cureus       Date:  2017-05-09

2.  Amiodarone-induced pulmonary toxicity with an excellent response to treatment: A case report.

Authors:  Fabrizio Terzo; Alberto Ricci; Michela D'Ascanio; Salvatore Raffa; Salvatore Mariotta
Journal:  Respir Med Case Rep       Date:  2019-11-29

3.  A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia.

Authors:  Luigi Cappannoli; Alessandro Telesca; Roberto Scacciavillani; Edoardo Petrolati; Andrea Smargiassi; Alessia Rabini; Massimo Massetti; Filippo Crea; Nadia Aspromonte
Journal:  Future Cardiol       Date:  2020-12-17

4.  Crucial Role of PLGA Nanoparticles in Mitigating the Amiodarone-Induced Pulmonary Toxicity.

Authors:  Amira Motawea; Dalia Alsaied Moustafa Ahmed; Ahmed A El-Mansy; Noha Mohamed Saleh
Journal:  Int J Nanomedicine       Date:  2021-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.